1. Home
  2. HCAI vs BGLC Comparison

HCAI vs BGLC Comparison

Compare HCAI & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HCAI

Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

HOLD

Current Price

$7.15

Market Cap

6.3M

ML Signal

HOLD

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.14

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAI
BGLC
Founded
2004
2017
Country
China
Malaysia
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.3M
5.2M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
HCAI
BGLC
Price
$7.15
$2.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
14.8M
2.1K
Earning Date
05-23-2026
04-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.78
EPS
N/A
N/A
Revenue
N/A
$7,424,911.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$63.07
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$1.92
52 Week High
$10.60
$15.19

Technical Indicators

Market Signals
Indicator
HCAI
BGLC
Relative Strength Index (RSI) 63.11 40.46
Support Level $0.41 $2.14
Resistance Level $8.75 $2.73
Average True Range (ATR) 1.10 0.06
MACD 0.44 0.00
Stochastic Oscillator 69.71 0.00

Price Performance

Historical Comparison
HCAI
BGLC

About HCAI Huachen AI Parking Management Technology Holding Co. Ltd. Ordinary Shares

Huachen AI Parking Management Technology Holding Co Ltd is a comprehensive smart parking solutions and equipment structural parts provider. The company manufactures and offer various cubic parking garage products by employing various working principles, such as lifting and shifting, convenient lifting, vertical circulation, vertical lifting, plane moving, alley stacking, multi-layer cycle, horizontal cycle, and car lift.

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

Share on Social Networks: